Clinical Trial Update: Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing bimatoprost 0.03% with travoprost 0.004% in patients already using latanoprost, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost 0.03% (bimatoprost)
• Latanoprost 0.005% (latanoprost)
• Travoprost 0.004% (travoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2008-09-26